Latest Strategic Review News

Classic Minerals has engaged AFDC to conduct a strategic review and is raising A$3 million to advance exploration at its Forrestania gold project and support its ASX relisting efforts.

Dataworks Group Limited reveals ongoing strategic review with several parties engaged, highlighting the value of its self-exclusion technology and regulatory ties. While discussions remain preliminary, the company signals potential for significant strategic moves ahead.

Perseus Mining has agreed to sell its majority interest in the Meyas Sand Project in Sudan for US$260 million, marking a strategic shift amid regional conflict. The deal will bolster Perseus’s balance sheet and refocus resources on core assets.

Elanor Investors Group reported a $57 million statutory loss for FY25 but is progressing a $125 million recapitalisation with Rockworth Capital Partners to stabilise its balance sheet amid ongoing financial challenges.

OM Holdings reported a modest decline in FY2025 revenue and EBITDA amid subdued market conditions but maintains a positive cash position and sets a stable production outlook for FY2026.

Energy World Corporation appoints Alan Jowell as Executive Chairman to spearhead its strategic review and project development, while exploring asset sales alongside its flagship Pagbilao LNG and Power Project.

Pengana International Equities has dismissed an unauthorized announcement about management changes and outlined plans for a shareholder buy-back and potential special dividend amid its strategic review.

Endeavour Group reported a solid first half for fiscal 2026 with underlying EBIT of $563 million, supported by retail price leadership and strong hotel sales growth. The group raised capital expenditure guidance, reflecting accelerated hotel renewals and strategic investments.

Leeuwin Metals reports promising step-out drilling results at its Evanston prospect within the Marda Gold Project, revealing shallow gold mineralisation beyond existing resources and signalling potential for resource expansion.

Opthea Limited reports a striking turnaround with a $339.9 million profit for H1 2026, driven by a strategic refocus on developing OPT-302 for Lymphangioleiomyomatosis (LAM), a rare lung disease affecting women. The company plans a rebrand and ASX reinstatement as it charts a new course in rare respiratory health.

MCS Services Limited has reported a significantly reduced half-year loss and announced plans to sell its Highways Traffic subsidiary, aiming to strengthen its financial position amid ongoing challenges.

Clime Investment Management reports a strong half-year operating profit surge and proposes a fully franked interim dividend, while streamlining its business to target sophisticated investors.